Text message support for teens staying on HIV treatment
Part of Infections clinical trials.
This study tests whether regular text messages and small rewards help teenagers keep taking their HIV medicine every day. It aims to make it easier for teens to stay healthy and stick with their treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 19 years old.
- You have been taking HIV medicine (ART) for at least one year.
- You plan to continue your HIV treatment at the same clinic during the study.
- You are willing to receive text messages and possibly earn small rewards.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether daily text message reminders and a small tracking device (WisePill) can help people who recently started HIV medication stay on track. It's designed for people who began treatment in the past 2 months and are willing to receive texts and use the device.
This study tests a program that uses text messages and a personal health coach to help Latino men with HIV take their medication every day. It's designed for those who have had trouble sticking to their HIV medicine routine.
This study tests a program called Motivation Matters! to help people with HIV who have traded sex for things they need get started on HIV medication and stay healthy. It uses text messages to support you.
This trial tests an mHealth (phone-based) program to help women with HIV improve health outcomes. It targets people who have had recent challenges with clinic visits, detectable virus levels, or taking HIV medicines.
This trial tests a program to help people with HIV stay on track with their medication. If you take HIV medication, sometimes miss doses, and use stimulants, this program may offer support to improve your health.
This study looks at a way to help people take their HIV medicines as prescribed. It focuses on people who are HIV-positive and not currently taking their treatment consistently.
Hear when a new Antiretroviral Therapy (ART) Adherence Among Adolescents Living With HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.